4.3 Review

Chronic abdominal pain in irritable bowel syndrome - current and future therapies

期刊

EXPERT REVIEW OF CLINICAL PHARMACOLOGY
卷 11, 期 7, 页码 729-739

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1080/17512433.2018.1494571

关键词

Irritable bowel syndrome; visceral pain; chronic pain; pharmacotherapy; pain management; microbiota

资金

  1. Medical University of Lodz [503/1-156-04/503-11-001]

向作者/读者索取更多资源

Introduction: Irritable bowel syndrome (IBS) is a functional gut disorder that typically manifests in early adult years. One of the two major symptoms of the disease is chronic, visceral pain. The patients report pain as the most distressing symptom with the greatest impact on quality of life, challenging both to patients and healthcare providers. Areas covered: This review focuses on the pathophysiology of abdominal pain in IBS and describes current treatment possibilities. It also covers latest findings that may lead to novel pharmacological options in IBS pain management. Expert commentary: Pain is the main contributor to severity in IBS. Seeking pain alleviation is the most common reason that IBS sufferers consult with their physicians. Not all patients report being satisfied with available treatments for pain in IBS and there is a pressing need to find new, more efficient therapies for this syndrome.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据